Signed in as:
filler@godaddy.com
RESEARCH NEWS
Potential drug target for BRCA-mutated tumours
Breastcancer breackthrough - Professor Andrew Tott
Potential drug target for BRCA-mutated tumours
Scientists identify potential drug target for BRCA-mutated tumour
ICR The Institute Of Cancer Research
Breastcancer breackthrough - Professor Andrew Tott
Potential drug target for BRCA-mutated tumours
Our mission is to make the discoveries that defeat cancer. Welcome to a very special edition of Search, which focuses on our new Centre for Cancer Drug Discovery
Breastcancer breackthrough - Professor Andrew Tott
Breastcancer breackthrough - Professor Andrew Tott
New evolution-busting drug overcomes resistance in aggressive breast cancers
Trial shows benefits of targeted drug against early-stage breast cancer with inherited BRCA mutation
New evolution-busting drug overcomes resistance in aggressive breast cancers
Personalised ‘liquid biopsy’ could detect return of breast cancer nearly eleven months earlier tha
New evolution-busting drug overcomes resistance in aggressive breast cancers
A new type of drug that blocks one of cancer’s key evolutionary escape routes from chemotherapy could be used to treat aggressive breast cancers, a new study has shown
Personalised ‘liquid biopsy’ could detect return of breast cancer nearly eleven months earlier tha
Personalised ‘liquid biopsy’ could detect return of breast cancer nearly eleven months earlier tha
Personalised ‘liquid biopsy’ could detect return of breast cancer nearly eleven months earlier tha
A personalised blood test for women with early breast cancer could detect the return of the disease nearly eleven months earlier than hospital scans
Cancer trades in sugar for fatty acids in order to spread around the body
Personalised ‘liquid biopsy’ could detect return of breast cancer nearly eleven months earlier tha
Personalised ‘liquid biopsy’ could detect return of breast cancer nearly eleven months earlier tha
Scientists have uncovered a crucial change in cancer cells that allows them to spread around the body – by switching from sugar to fatty acids to fuel their growth
Display real testimonials
A potential treatment for therapy-resistant breast cancer patients has been uncovered by researchers
Share the big news ASCO 2019: New blood test predicts breast cancer’s return at start of treatment
The targeted cancer drug olaparib has been approved by the European Medicines Agency (EMA) for women and men with advanced breast cancer who have inherited BRCA gene mutations
Share the big news ASCO 2019: New blood test predicts breast cancer’s return at start of treatment
A potential treatment for therapy-resistant breast cancer patients has been uncovered by researchers
Share the big news ASCO 2019: New blood test predicts breast cancer’s return at start of treatment
Dr Ben O’Leary discusses a new blood test for women with advanced breast cancer which can predict how well patients will respond to a new drug
A potential treatment for therapy-resistant breast cancer patients has been uncovered by researchers
A potential treatment for therapy-resistant breast cancer patients has been uncovered by researchers
A potential treatment for therapy-resistant breast cancer patients has been uncovered by researchers
The European Cancer Stem Cell Research Institute, based with Cardiff University, has repurposed a current cancer therapy, TRAIL, to find a new treatment for advanced cancers that are resistant to anti-hormone therapy
Cell shape ‘maps’ could point to new cancer treatments
Cell shape ‘maps’ could point to new cancer treatments
A potential treatment for therapy-resistant breast cancer patients has been uncovered by researchers
Scientists have created a ‘map’ linking the shape of breast cancer cells to the activation of their genes, which could point towards new treatments and help improve the effectiveness of immunotherapies
